US Patent Issued to AMISTEC on Dec. 2 for "Zinc molybdate having a triclinic crystal structure, as an antimicrobial agent" (Austrian Inventor)

ALEXANDRIA, Va., Dec. 2 -- United States Patent no. 12,484,585, issued on Dec. 2, was assigned to AMISTEC GMBH & Co. KG (Kossen in Tirol, Austria).

"Zinc molybdate having a triclinic crystal structure, as an antimicrobial agent" was invented by J. Peter Guggenbichler (Kossen in Tirol, Austria).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are methods of using a triclinic form of zinc molybdate (ZnMoO4) as an antimicrobial agent, composite materials which include antimicrobial zinc molybdate, and processes for the production thereof, including ultrasound mediated processes for the production of triclinic zinc molybdate with a controlled average grain size."

The patent was filed on Oct. 25, 2019, un...